June 26th 2025
At 12 weeks, patients treated with ENV-101 showed statistically significant increases in lung volume compared with those receiving placebo.
Learn about the clinical and economic burden of idiopathic and progressive pulmonary fibrosis; the need for earlier diagnosis and improved care coordination; and emerging therapies that may close treatment gaps.